Stocks and Finance

Vertex Pharmaceuticals

Vertex Pharmaceuticals 1/31/2012

13:49 : Vertex Pharmaceuticals (VRTX) comes off a trading halt after tripping ... - Vertex Pharmaceuticals (VRTX) comes off a trading halt after tripping circuit breaks still showing a solid 7.4% gain on momentum built from the firm's FDA approval for Kalydeco. Sanford Bernstein analyst Geoffrey Porges sees ...
Source : seekingalpha-com

Vertex Pharmaceuticals 12/15/2011

12:27 : Vertex Pharmaceuticals ([[VRTX]] +1.4%) says the FDA has accepted a New ... - Vertex Pharmaceuticals (VRTX +1.4%) says the FDA has accepted a New Drug Application for its cystic-fibrosis drug Kalydecotm, and granted the company's request for six-month priority review. The drug targets the defective ...
Source : seekingalpha-com

Vertex Pharmaceuticals 11/10/2011

14:07 : Vertex Pharmaceuticals ([[VRTX]] +3.7%) jumps on a Morgan Stanley upgrade - Vertex Pharmaceuticals (VRTX +3.7%) jumps on a Morgan Stanley upgrade to Equalweight on valuation. Morgan cites the company's solid pipeline, and adds that data on competitors in the hepatitis C treatment ...
Source : seekingalpha-com
actualidad Vertex Pharmaceuticals -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts